DUO-E Trial
Does adding durvalumab (a PD-L1 inhibitor) and olaparib (a PARP inhibitor) to standard chemotherapy improve outcomes in advanced or recurrent endometrial cancer?
Shitanshu Uppal
Open Radical Hysterectomy
Radical Hysterectomy Tutorial
Publications Update # 40
RHIP framework for change, MIRASOL and CALLA summaries
Publications Update # 39
Gratitude as a habit, sentinel lymph node dissection in EIN/CAH, cervical cancer practice guidelines and TPN in patients with an enterocutaneous fistula
Mental Health Crisis in Surgeons
Anxiety, bipolar and addictions
Perfection
How to avoid the perfection trap
Trauma Stewardship
Self-care baby steps, tiny survival guide, and how to make a grilled cheese sandwich
Publications Update # 37
3 Practices for Wisdom and Wholeness
Learn on how to recognize the generative narrative of abundant reality, living with the question and embracing your calling.
Publications Update # 36
Non-Medical Article of the Week
3 practices for wisdom and